Glen Tullman, the former Allscripts CEO who left the company at the end of 2012 by mutual agreement, is back in the health field. His newest venture, Livongo, launched from the stage of TechCrunch’s Disrupt conference in San Francisco and has already raised a $10 million funding round from General Catalyst Partners.
“Our plan is to use the experience gained in Silicon Valley on consumer empowerment, deep healthcare experience, and cutting-edge global cellular technology to provide solutions that empower people with diabetes and their support teams … to focus on living their on-the-go lives, not on their chronic conditions,” Tullman wrote in an email. “We want to use the same principles that made it easy to order music, read books, store pictures, stay connected with people, and yes, even order a taxi, and apply them to healthcare.”
Tullman has been working on this project since at least May of last year, when MobiHealthNews caught up with him and received some hints about what Livongo would be: a consumer-centric venture aimed at improving the management of chronic diseases.
“We need to stop thinking of people as patients,” Tullman said at the time. “Health should be consumer-centric. When it doesn’t work, then it becomes patient-centric.”
Livongo Health will aim to engage all kinds of people with diabetes — old and young, type 1 and type 2 — in the management of their care. The platform will consist of connected devices, a smart cloud, and a virtual care team. Keep reading>>